WebMaria Fardis is the Executive Chair of Obsidian’s Board of Directors and a Venture Partner at Frazier Life Sciences. She has over 20 years of scientific and management experience in numerous public and private companies. Dr. Fardis previously served as President and Chief Executive Officer of Iovance Biotherapeutics. WebApr 12, 2024 · Maria Fardis, Ph.D., MBA, has been a venture partner at Frazier Life Sciences since 2024. Dr. Fardis previously served as President and CEO of Iovance …
Maria Fardis - Venture.. - Frazier Healthcare Partners ZoomInfo
WebFrazier Healthcare Partners's key executives include James Topper and 39 others. James Topper. Managing Partner. Patrick Heron. Managing Partner. Ben Magnano. ... Maria … WebMaria Fardis, PhD, is a Venture Partner at Frazier Life Sciences and is the Chair of Board of Directors at Obsidian Therapeutics. She is a member of the Board of Directors at CRISPR Therapeutics as well as Quanta Therapeutics. She has over 20 years of scientific and management experience in public and private companies. Dr. hunnernas kung
Frazier Healthcare Partners Adds Highly Experienced …
WebMay 21, 2024 · Iovance Biotherapeutics Chief Executive Officer Maria Fardis has resigned from her position following another setback in the company’s hopes to secure regulatory approval for its tumor-infiltrating lymphocyte (TIL) therapy candidate lifileucel as a potential treatment for melanoma.. Earlier this week, the U.S. Food and Drug Administration … WebSep 22, 2024 · Frazier Healthcare Partners announced the addition of Maria Fardis, Ph.D. as a Venture Partner on the Life Sciences team. She has over 20 years of scientific and management experience in numerous ... WebFardis has been a venture partner at Frazier Life Sciences since 2024. Dr. Fardis previously served as President and Chief Executive Officer of Iovance Biotherapeutics, Inc. … hunni laubinger